See All Slides -

Slides

Presentation TCT 2016

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

Presenter: Howard C. Herrmann, Robert J. de Winter, David E. Thaler

November 01, 2016

Presentation TCT 2016

Lesion Optimization Before PCI: Role of Imaging/Atherectomy

Presenter: Sripal Bangalore, George D. Dangas, Philippe Généreux

November 01, 2016

Presentation TCT 2016

Optimal Approach to Persistent Type II Endoleaks with Sac Expansion

Presenter: Peter A. Schneider, Barry T. Katzen

November 01, 2016

Presentation TCT 2016

Hybrid Coronary Revascularization: Results to Date (From Meta-analysis to the NIH Multicenter Observational Study)

Presenter: John D. Puskas, Gregg W. Stone

November 01, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials III - Stellarex

Presenter: Koen Deloose, William A. Gray, Prakash Krishnan

November 01, 2016

Presentation TCT 2016

What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia?

Presenter: John A. Ambrose, Peter H. Stone

November 01, 2016

Presentation TCT 2016

Post-TAVR Valve Thickening: Current Data and Open Questions

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min, Hasan Jilaihawi

November 01, 2016

Presentation TCT 2016

Hot: Is High Dose Due to Operator Preferences or Patient Characteristics?

Presenter: Stephen Balter, Sanjog Kalra

November 01, 2016

Presentation TCT 2016

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients!

Presenter: Andreas Baumbach, David Hildick-Smith, Wilson Y. Szeto

November 01, 2016

Presentation TCT 2016

Debate: Imaging For TAVR- The Case for TEE and MAC/GA!

Presenter: Patrizio Lancellotti, Sunil V. Mankad, Rebecca T. Hahn

November 01, 2016

Advertisement

Slides

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

Lesion Optimization Before PCI: Role of Imaging/Atherectomy

Optimal Approach to Persistent Type II Endoleaks with Sac Expansion

Hybrid Coronary Revascularization: Results to Date (From Meta-analysis to the NIH Multicenter Observational Study)

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials III - Stellarex

What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia?

Post-TAVR Valve Thickening: Current Data and Open Questions

Hot: Is High Dose Due to Operator Preferences or Patient Characteristics?

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients!

Debate: Imaging For TAVR- The Case for TEE and MAC/GA!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content